Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Chip Somodevilla/Getty Images)

Sen. Mitt Romney (R-Utah) on Wednesday criticized his Republican colleagues on the Senate Homeland Security Committee for their probe into Joe Biden and his son's dealings in Ukraine, saying that it has the "earmarks of a political exercise."

Why it matters: Sen. Ron Johnson (R-Wis.), who is leading the investigation, told supporters on Monday that "in about a week we’re going to learn a whole lot more of Vice President Biden’s unfitness for office." The committee is investigating Hunter Biden's work for Ukrainian gas company Burisma at a time when Joe Biden was leading the Obama administration's Ukraine policy.

What he's saying: "[The investigation] from the outset had the earmarks of a political exercise," Romney said at a hearing on Wednesday. "I'm fearful that comments made in the media recently have only confirmed that perspective."

  • “It’s not the legitimate role of government, for Congress or for taxpayer expense, to be used in an effort to damage political opponents."
  • "I do believe it's very important that the committees of Congress, and ours in particular, not fall into an increasing pattern that we're seeing, which is using taxpayer dollars and the power of Congress to do political work. That's the role of campaigns."

The big picture: Romney's comments came after Johnson cancelled a vote that would have issued a subpoena to U.S. Ambassador to Slovakia Bridget Brink as part of the Burisma probe.

  • The committee did, however, authorize subpoenas on Wednesday targeting former Obama administration officials' roles during the transition to the Trump administration. Romney voted in favor of those subpoenas.
  • Romney said the probe on the Obama officials could dodge "obvious political implications" by focusing on specific allegations alleged in a report by DOJ Inspector General Michael Horowitz.

Flashback: Romney in March said the investigation "appears" politically motivated. But a spokesperson for the senator said the next day he changed his mind after receiving assurances from Johnson that the probe would be handled behind closed doors.

Go deeper: Ron Johnson denies that theory of Ukrainian election interference is "debunked"

Go deeper

Dec 18, 2020 - Politics & Policy

Sen. Ron Johnson blocks Hawley bill proposing $1,200 stimulus checks

Sen. Ron Johnson (R-Wis.) on Friday objected to Sen. Josh Hawley's (R-Mo.) motion to pass a bill via unanimous consent that would provide $1,200 to Americans in the form of direct stimulus checks, citing the ballooning national debt.

Why it matters: Hawley has teamed up with an unlikely partner, Sen. Bernie Sanders (I-Vt.), in a push to include direct payments in Congress' next coronavirus relief package, which has entered the final stages of negotiations.

55 mins ago - Health

Pfizer coronavirus vaccine safe, effective in children, company says

Photo by Mario Tama/Getty Images

Pfizer and BioNTech's coronavirus vaccine is safe and effective in children ages 5 to 11, albeit at a lower dose than adults receive, the companies said in a press release announcing results from a pediatric trial.

Why it matters: The trial results are a much-needed source of hope for families with elementary school-aged children, who currently aren't eligible for a vaccine.

The pandemic made our workweeks longer

Illustration: Annelise Capossela/Axios

The average American's workweek has gotten 10% longer during the pandemic, according to a new Microsoft study published in Nature Human Behaviour.

Why it matters: These longer hours are a key part of the pandemic-induced crisis of burnout at U.S. firms — and workers are quitting in droves.